Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis

Am J Epidemiol. 1995 Sep 15;142(6):608-11. doi: 10.1093/oxfordjournals.aje.a117682.

Abstract

This study examines the hypothesis that low serum levels of vitamin D metabolites are associated with an increased risk for colon cancer. From August through November 1974, 20,305 residents of Washington County, Maryland, donated blood for storage at -70 degrees C in a serum bank. Colon cancer was subsequently diagnosed among 57 of these residents during the period 1984-1991. Controls had donated blood in 1974 and remained free of colon cancer through the date of diagnosis of the case. Two controls were matched to each case on age (+/- 1 year), race, sex, and date of blood draw (+/- 1 month). Mean 25-hydroxyvitamin D levels were 23.6 ng/ml and 23.2 ng/ml, and mean 1,25-dihydroxyvitamin D levels were 34.7 pg/ml and 34.6 pg/ml, in cases and controls, respectively. Analysis by quintile of serum level similarly found that none of the 95% confidence intervals of the odds ratios excluded unity, and a dose-response effect was not observed. Our data provide no strong support for the hypothesis that vitamin D metabolite levels affect the subsequent risk for colon cancer.

MeSH terms

  • Blood Donors
  • Case-Control Studies
  • Cohort Studies
  • Colonic Neoplasms / blood
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / etiology*
  • Female
  • Humans
  • Male
  • Maryland
  • Odds Ratio
  • Time Factors
  • Vitamin D / blood*

Substances

  • Vitamin D